glp-1 obesity treatment Weight Reduction with Agonists and Paths for Discontinuation While Maintaining Weight Loss GLP-1 Weight Loss Medications Explained:

Weight management benefits are clinically meaningful, with combined therapy typically resulting in 2-5 kg weight loss over 6-12 months at diabetes doses

Current clinical consensus reflects the following: Research findings are preliminary and insufficient to guide treatment decisions No regulatory approval exists for using GLP-1s in addiction treatment Early signals do not outweigh the lack of long-term outcome data Instead, clinicians continue to recommend established, evidence-based approaches, including: Behavioral therapies tailored to substance use disorders Medication-assisted treatment when medically indicated Comprehensive psychosocial support and relapse-prevention planning Comprehensive assessment remains a cornerstone of safe and effective care

And lastly, GLP-1 slows gastric emptying , resulting in a prolonged feeling of fullness

If patients need to go from a GLP-1 to bariatric surgery, how do we make that switch as seamless as possible? she said

Comparing GLP-1 Medications: Key Differences and Considerations Choosing among the various GLP 1 options requires understanding key differences in dosing frequency, efficacy and practical considerations around cost and access

While Dr